Skip to main content
OpenTrials
Completed

NCT Number: NCT03539276

An Intervention to Reduce Inappropriate Medications in Long-term Care Residents With Severe Dementia

An education intervention to promote medication reviews and interdisciplinary discussions within long-term care facilities with the aim of improving medication regimen among residents with severe dementia

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dementia Brain Diseases Central Nervous System Diseases Inappropriate Prescribing Mental Disorders Nervous System Diseases Neurocognitive Disorders

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale

Québec, Canada

About this study

A quasi-experimental study in three long-term care facilities. The intervention comprises an information leaflet for families of residents, a 90-minute knowledge exchange session for general practitioners, pharmacists and nurses and a list of "generally", "sometimes", and "exceptionally" appropriate medications for severe dementia residents

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosis of dementia of any etiology
  • severe dementia

Exclusion criteria

  • admission less than 2 months before intervention

Treatment and study plan

Knowledge exchange

Behavioral

OptimaMed

Primary outcomes

  1. Medication regimen

    Time frame: Four months post intervention

    Active prescriptions

Secondary outcomes

  1. Level of pain

    Time frame: Four months post intervention

    Pain Assessment Checklist for Seniors with Limited Ability to Communicate (PACSLAC).

    The French version of the PACSLAC tool is a validated observational scale in use in Quebec to assess discomfort / pain.

    One point is added to the score for each PACSLAC item (n=60) observed over a 15-minute observation period; the sum of the four 15-minute observation periods gives the total score. The total score ranges from zero to sixty where zero represents no discomfort or pain and sixty a very high level of discomfort or pain.

  2. Level of agitation

    Time frame: Four months post intervention

    Cohen-Mansfield Agitation Inventory () measures level of agitation. Sum of the number of times the Cohen-Mansfield Agitation Inventory items were observed during the four 15-minute observation periods.. The total score ranges from zero to one hundred where zero represents no agitation and one hundred a very high level of agitation.

Sponsors and collaborators

Lead sponsor

CHU de Quebec-Universite Laval

Other

Collaborators

  • Fonds de la Recherche en Santé du Québec
  • McGill University
  • Université de Montréal
  • Université de Sherbrooke

Registry information

Official study title

The OptimaMed Intervention to Reduce Inappropriate Medications in Long-term Care Residents With Severe Dementia: Results From a Quasi-experimental Intervention Study

Acronym: OptimaMed

Important dates

Study start
2014
Primary completion
2014
Study completion
2015
First posted
May 29, 2018
Registry last updated
Jun 1, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.